Skip to main content

Table 1 Comparison between the three studied groups according to age, sex, diabetic medication and duration of diabetes

From: A comparative study of Botulinum toxin type A versus conventional oral therapy as a second-line treatment of diabetic neuropathy

 

Duloxetine (n = 10)

Gabapentin (n = 10)

Botox (n = 10)

Test of sig

p

Sex

 Male

5 (50%)

4 (40%)

4 (40%)

χ2 = 0.381

MCp = 1.000

 Female

5 (50%)

6 (60%)

6 (60%)

Age (years)

 Mean ± SD

59.9 ± 7

59.1 ± 9.4

60.9 ± 9.8

F = 0.105

0.900

 Median (Min.–Max.)

59.5 (50–70.0)

58 (45–72)

62 (47–76)

Medication

 Oral

6 (60%)

9 (90%)

8 (80%)

χ2 = 2.400

MCp = 0.430

 Insulin

4 (40%)

1 (10%)

2 (20%)

Duration (years)

 Mean ± SD

9.2 ± 6.4

6.4 ± 4.4

9.6 ± 6.2

H = 1.712

0.425

 Median (Min.–Max.)

7 (3–24)

5 (2–16)

9 (2–20)

  1. SD: standard deviation; χ2: Chi-square test; F: F for ANOVA test; MC: Monte Carlo; H: H for Kruskal–Wallis test
  2. p: p value for comparing between the three studied groups